Form 8-K - Current report:
SEC Accession No. 0000950133-01-502046
Filing Date
2001-08-01
Accepted
2001-08-01 00:00:00
Documents
7
Period of Report
2001-07-03
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT w51978e8-k.htm 8-K 12139
3 SERIES B CONVERTIBLE PREFERRED STOCK w51978ex3-1.htm EX-3.1 80462
4 FORM OF CLASS E WARRANT w51978ex4-1.htm EX-4.1 72292
5 FORM OF CLASS F WARRANT w51978ex4-2.htm EX-4.2 77786
6 SECURITIES PURCHASE AGREEMENT w51978ex10-1.htm EX-10.1 128149
7 REGISTRATION RIGHTS AGREEMENT w51978ex10-2.htm EX-10.2 91560
8 OPTION TO PURCHASE SERIES B CONVERTIBLE STOCK w51978ex10-3.htm EX-10.3 24655
  Complete submission text file 0000950133-01-502046.txt   489427
Mailing Address 300 PROFESSIONAL DRIVE GAITHERSBURG MD 20879
Business Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879 3015900129
ANTEX BIOLOGICS INC (Filer) CIK: 0000893692 (see all company filings)

EIN.: 521563899 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-16075 | Film No.: 1695180
SIC: 2836 Biological Products, (No Diagnostic Substances)